Inventor · disambiguated record
Daniela Cocconi
Also filed as: COCCONI DANIELA
9 granted patents·11 pending applications·21 citations·filing 2005–2023
82Inventor score
Top patents by PatentIndex Score
20 records- 0185US8778402B2Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalationCHIESI FARMA SPA·Filed 2013·Granted Jul 15, 2014·12 cites·21 claims
- 0277US10028964B2Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalationCHIESI FARM SPA·Filed 2013·Granted Jul 24, 2018·4 cites·15 claims
- 0377US2023364015A1Process for providing particles with reduced electrostatic chargesCHIESI FARM SPA·Filed 2023·Application pending·0 cites
- 0472US9132121B2Dry powder formulation comprising a phosphodiesterase inhibitorCOCCONI DANIELA·Filed 2011·Granted Sep 15, 2015·4 cites·22 claims
- 0567US2019216731A1Process for providing particles with reduced electrostatic chargesCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 0664US10946029B2Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalationCHIESI FARM SPA·Filed 2018·Granted Mar 16, 2021·0 cites·12 claims
- 0763US8512753B2Micronized particles of low-dosage strength active agents for powder formulations for inhalationMUSA ROSSELLA·Filed 2009·Granted Aug 20, 2013·1 cites·11 claims
- 0861US2009192187A1Dry powder formulation comprising an anticholinergic drugCHIESI FARMA SPA·Filed 2008·Application pending·0 cites
- 0961US2011097409A1Particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone having improved adhesion properties for powder formulations for inhalationCHIESI FARMA SPA·Filed 2009·Application pending·0 cites
- 1057US2011262543A1Process for providing particles with reduced electrostatic chargesCHIESI FARMA SPA·Filed 2011·Application pending·0 cites
- 1153US2025050042A1Dry powder formulations filled in an inhaler with improved resistance to humidityCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1247US2018133161A1Use of magnesium stearate in dry powder formulations for inhalationCHIESI FARM SPA·Filed 2018·Application pending·0 cites
- 1346US9308200B2Dry powder formulation comprising a phosphodiesterase inhibitorCHIESI FARMA SPA·Filed 2015·Granted Apr 12, 2016·0 cites·20 claims
- 1443US9445999B2Process for preparing carrier particles for dry powders for inhalationCHIESI FARM SPA·Filed 2015·Granted Sep 20, 2016·0 cites·18 claims
- 1543US8974831B2Process for preparing carrier particles for dry powders for inhalationMUSA ROSSELLA·Filed 2011·Granted Mar 10, 2015·0 cites·13 claims
- 1643US2016354314A1Process for preparing carrier particles for dry powders for inhalationCHIESI FARM SPA·Filed 2016·Application pending·0 cites
- 1741US2010269825A1Inhalation particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1h)-quinolinone and a corticosteroidCHIESI FARMA SPA·Filed 2010·Application pending·0 cites
- 1840US2015320691A1Use of magnesium stearate in dry powder formulations for inhalationCHIESI FARMA SPA·Filed 2015·Application pending·0 cites
- 1938US2012082727A1Use of magnesium stearate in dry powder formulations for inhalationCOCCONI DANIELA·Filed 2011·Application pending·0 cites
- 2034US8153104B2Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredientBILZI ROBERTO·Filed 2005·Granted Apr 10, 2012·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →